Subscribe
Sign in
Home
News
Capital
Deals
Views
Intelligence
About
Women's Health
Latest
Top
Discussions
What Novo Nordisk’s Failed Heart-Drug Trial Really Tells Investors
What ZEUS means for Novo’s pipeline and how far investors should apply its result.
Aug 4
•
Maryann
11
4
3
The People Building the Future of Women’s Health
The Billion Dollar Blindspot is opening its pages to founders, investors, clinicians, researchers and industry leaders with valuable perspectives to…
Aug 2
•
Maryann
10
4
3
The Questions Nobody Funded: ADHD in Women and the Hidden Economics of Medical Research
What one rejected study reveals about research funding, hormones, perimenopause and why some of medicine's most important questions remain unanswered.
Jul 19
•
Maryann
53
8
14
When Women's Health Meets Institutional Capital
Why venture capital growth alone may not be enough for women's health to become an institutional investment category.
Jul 12
•
Maryann
16
5
Why Women's Health Is the First Test of Precision Health
Women's health is one of the clearest tests of precision healthcare. Discover why biological time is reshaping medicine, innovation and healthcare…
Jun 28
•
Maryann
14
6
When Care Becomes Leverage: Who Owns Women’s Health Infrastructure?
Women’s health needs more capital. But as clinics consolidate, the more urgent question is whether ownership models protect continuity of care, clinical…
Jun 21
•
Maryann
29
5
9
Being Diagnosed Isn't the Same as Being Studied
Women with ADHD are being treated with medications whose pivotal trials never tracked menstrual cycle phase, hormonal variability, or perimenopausal…
Jun 14
•
Maryann
24
7
Was ADHD Built for Boys? Why Thousands of Women Are Being Diagnosed Decades Later
Why are so many women being diagnosed with ADHD in their 40s and 50s? This article explores the history of ADHD research, the possibility of diagnostic…
Jun 7
•
Maryann
44
18
6
Women Now Spend a Third of Their Lives After Menopause. Medicine Hasn't Caught Up.
For decades, medicine treated estrogen primarily as a reproductive hormone. New evidence suggests we may have misunderstood what it was doing all along.
May 31
•
Maryann
49
5
14
Why Women’s Health Became a Billion-Dollar Blind Spot in Capital Markets
Why women’s health remained overlooked for decades, how incomplete data created market blind spots and why investors are finally paying attention.
May 24
•
Maryann
53
22
16
The Billion Dollar Blind Spot Began in a Doctor’s Office
The story behind The Billion Dollar Blind Spot and the structural forces reshaping healthcare innovation and capital allocation.
May 17
•
Maryann
15
2
4
The Future of Medicine Is Being Built on Incomplete Biology
A new Nature Neuroscience commentary warns that phasing out animal research before female biology is well understood could lock historical male bias…
May 9
•
Maryann
32
4
9
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
